EXH2123033810

PCHBPollution Control Hearings Board of the State of Washington

QuickView -- Antimony; 7440-36-0 Page 1of 2 .EPA EnvitonntenlalProtection , _- Agency Integrato_ _sk InlormatJo,_ 5vs:om u zc K Vt E W ,ISelect a Substance __ ,_2,_ view Eu.!lIRIS Summa.ry _ QuickView c Full IRIS Summary Antimony (CASRN 7440-36-0) Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of toxicity data by U.S. EPA health scientists from several Program Offices, Regional Offices, and the Office of Research and Development. Disclaimer: This QuickView represents a snapshot of key information. We suggest that you read the Ft!!!!R!SSummar3. to put this information into complete context. For definitions of terms in the IRIS Web site, refer to theIRIS Glossary. Status of Data for Antimony ............... File First On-Line: 01/31/1987 Last Significant Revision: 02/01/1991 Category Status Last Revised Oral RID Assessment On-line 02/01/1991 Inhalation RfC Assessment No data Carcinogenicity Assessment No data Chronic Health Hazard Assessments for Noncarcinogenic Effects Reference Dose for Chronic Oral Exposure (RfD) Critical Effect Experimental Dose UI'_ M.F RfD Longevity,blood LOAEL:0.35 1000 1 4x10-4 mg/kg-day glucose,and mg/kg-day cholesterol The Experimental Dose listed serves as a basis from which the Oral RID was derived. See Discqssi_)n_l!C_nversi_)11 [_iat_t()!_s;tl3._J..As:_u!npti(_r!sfor more details. Princi.l_a.!...Study Rat chronic oral bioassay, Schroeder et al., 1970 Conf.!den.cein the...Oral..RfD Study -- Low Database -- Low RFD -- Low Reference Concentration for Chronic Inhalation Exposure (RfC) Not Assessed under the IRIS Program. Carcinogenicity Assessment for Lifetime Exposure - Weight of Evidence.Characterization ......................................................................................................................... Not Assessed under the IRIS Program. AR 033810 Quantitative Estimate of Carcinogenic Risk…
V V